2nd Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$2,290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

International tax provisions in the context of comprehensive Tax Reform Administration's FY 2012 Revenue Proposals HR 942 - American Research and Competitiveness Act of 2011 (R&D Tax Credit)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 942 (112th)

Copyright/Patent/Trademark CPT

Intellectual Property and Patent Issues HR 1249 - America Invents Act S 23 - America Invents Act

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
HELEN RHEE —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th)

Health Issues HCR

Implementation of Health Care Reform PL 111-128 "Patient Protection and Affordable Care Act" (IPAB, Biosimilars, 340b) Reauthorization of Prescription Drug User Fee Act (no bill)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
MARA GUARDUCCI —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part B reimbursement and coverage of dialysis products, Medicare Part D issues, Part B reimbursement issues

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.